Introduction
============

*Yersinia pestis* is the causative agent of plague in humans and, in the absence of antimicrobial therapy, the mortality rate can approach 100%. In large parts of the world the threat from *Y. pestis* has declined substantially over time as a result of improvements in living conditions and in public health, including improved rodent control and antibiotics. However, a plague outbreak following the release of a biological weapon is a potential risk. The presence of *Y. pestis* in small rodent populations in which it is endemic ([@ref-20]; [@ref-4]; [@ref-1]) can cause human fatalities as a result of zoonotic transmission ([@ref-8]).

The black rat (*Rattus rattus*) has been a major host of *Y. pestis* for centuries and can be a reservoir for numerous other pathogens. Although most mammalian species can be infected experimentally with *Y. pestis*, many species fail to develop the high bacteraemia that is necessary to infect the flea vectors. The majority of mammalian species are therefore likely to be dead end hosts ([@ref-3]).

Molecular methods, and in particular PCR, have been widely used to identify *Y. pestis* in tissue samples and the plasminogen activator/coagulase (*pla*) gene, located on the pPCP1 plasmid has been used as a target in many studies ([@ref-11]; [@ref-15]; [@ref-19]; [@ref-20]). The *pla* gene is commonly used because it has a high copy number in *Y. pestis* (186 per bacterium) and can be detected relatively easily ([@ref-14]). The PcP plasmid, and the *pla* gene in particular, is involved in transmission of *Y. pestis* ([@ref-2]). The protein encoded by the *pla* gene induces fibrinolysis and degrades the extracellular matrix and basement membranes, these activities are thought to disrupt the host's ability to contain the bacteria ([@ref-17]). The acquisition by *Y. pestis* of PcP, and of another virulence plasmid, the pMT, is thought to have contributed to the evolutionary transformation of *Y. pestis* from the mainly gut-associated *Yersinia enterocolitica*, into a highly host-adapted mammalian blood-borne pathogen ([@ref-5]). 10.7717/peerj.2216/table-1Table 1*Y. pestis* primers used to prepare baits for Illumina Miseq sequencing.Primer NamePrimer sequenceTargetReferenceF1CAGTTCCGTTATCGCCATTGC*caf1*[@ref-13]F2TATTGGTTAGATACGGTTACGGTYpfur1GAAGTGTTGCAAAATCCTGCG*fur*[@ref-7]Ypfur2AGTGACCGTATAAATACAGGCYPtoxUAGGACCTAATATGGAGCATGAC*Ymt*[@ref-16]YPtoxURCGTGATTACCAGGTGCAACA

Results and Discussion
======================

Probes specific to *Y. pestis* hybridised with samples from a subset of each of the rodent species tested (12/33 *R. rattus*, 48/834 *R. norvegicus,* 3/163 *A. sylvaticus*, 2/35 *M. musculus*) giving a total of 65/1065 samples (6.1%) which tested positive on the array. However, none of the generic *Yersinia* probes hybridised in those samples for which a positive signal was recorded for the *Y. pestis* specific probes.

Further testing was then carried out at the University of Nottingham, including real-time PCR which targeted another region of the *Y. pestis* genome, the *caf1* gene, for which primers used were identified from the literature ([@ref-9]). A subset (23 samples) of the array-positive samples was tested further with primers for *pla* and *caf1*. Of these samples, 12 were positive for the *pla* gene and all were negative for the *caf1* gene. A total of 30 array-positive samples were also sent to colleagues in Berlin for further analysis by in solution-based sequence hybridisation, as described previously ([@ref-18]). Briefly, a DNA extract from the samples was fragmented and an aliquot was used to produce illumina libraries following a custom protocol ([@ref-12]). PCR amplicons from *Y. pestis* genes were used to enrich specific target DNA sequences in the rodent samples, the genes and primers used to make the baits are shown in [Table 1](#table-1){ref-type="table"}. The enriched samples were then sequenced using an illumina Miseq. The results indicated that the majority of reads aligned with the rat genome, and only a small number of reads aligned with the *pla* gene. No other reads mapped to any other gene from *Y. pestis*.

Although a homologue to the *pla* gene has previously been reported in bacteria found in *R. rattus* and *R. norvegicus* from the Netherlands ([@ref-10]), this is the first time, to the author's knowledge, that the bacterial homologue has been reported in *M. musculus* and *A. sylvaticus*. The potential discovery of a *pla* gene homologue in other rodent species, and on another continent than the species and locations in which it has previously been reported, suggests that the homologue could be more widely distributed than previously thought and may cause difficulties in accurate *Y. pestis* detection. The results found here supports other work which suggests that markers other than the *pla* gene should be included to help avoid false positive results when screening for *Y. pestis*, as has been stressed by [@ref-10]. This was recently confirmed by Hänsch et al., as they found evidence that the pla gene is present in some strains of *Escherichia coli* and *Citrobacter koseri* ([@ref-6]). It is not clear why the homologue was present in a larger percentage of *R. rattus* samples than in the other species tested; perhaps *R. rattus* carries more *E. coli* or *C. koseri*, but this is something that needs to be investigated further.

Materials and Methods
=====================

This work was part of a EU project (FP7 WildTech) to develop and use a microarray to detect zoonotic pathogens in rodent tissues. A sequence of the pPCP1 plasmid of the *Y. pestis* genome (CP000310.1) was obtained from the NCBI database for microarray probe design. Probes were designed using two publicly available software packages: OligoWiz (<http://www.cbs.dtu.dk/services/OligoWiz/>) and Unique Probe Selector (<http://array.iis.sinica.edu.tw/ups/>). All probes were checked for suitability using an *in silico* BLAST analysis. The results of the *in silico* analysis at the time indicated that the probe sequences were specific to *Y. pestis* and no cross-hybridisation should occur with eukaryotic or prokaryotic species. Primers were designed using the software Primer3 (<http://bioinfo.ut.ee/primer3-0.4.0/>). The sequence of each oligonucleotide probe specific to *Y. pestis* is given in [Table 2](#table-2){ref-type="table"}. During the confirmatory testing, both real-time PCR and end-point PCR were used. The primers used in standard end-point PCR and real-time PCR are shown in [Table 3](#table-3){ref-type="table"}. These probes were evaluated thoroughly for specificity using reference samples of genomic DNA from *Y. pestis* NCTC5923 Type strain and non-related pathogens before screening took place. The microarray platform used was the ArrayStrip from Alere Technologies GmbH (Jena, Germany).

Four different rodent species (*R. rattus, R. norvegicus, Mus musculus* and *Apodemus sylvaticus*) were screened for a number of zoonotic pathogens. Tissue samples were obtained from Vancouver (Canada), Liverpool (UK), and Lyon (France) as part of other studies. Automated nucleic acid extraction was performed on the samples using the QIAcube (Qiagen, Hilden, Germany) and the kit (Cador Pathogen Mini Kit; Qiagen, Hilden, Germany). Liver, kidney and lung tissues were available from each rodent sampled from Vancouver and Lyon, and extracted nucleic acid from each tissue was pooled to make a single sample per individual animal which was tested on the array. Only liver and kidney samples were available from the rodents sampled from Liverpool, and again, extracted nucleic acid was pooled to make a single sample. [Figure 1](#fig-1){ref-type="fig"} depicts the sequence enrichment and microarray hybridisation used in this study.

10.7717/peerj.2216/table-2

###### *Y. pestis* specific oligonucleotide probes used on the Alere ArrayStrip.

![](peerj-04-2216-g003)

  Probe               Sequence (5^′^--3^′^)                                          Pathogen      Gene target   Position[^a^](#table-2fn1){ref-type="fn"}
  ------------------- -------------------------------------------------------------- ------------- ------------- -------------------------------------------
  Y.pestis_Owiz_117   TACAGATCATATCTCTCTTTTCATCCTCCCCTAGCGGGGAGGATGTCTGTGGAAAGGAGG   *Y. pestis*   pPCP1         8781--8840
  Y.pestis_Owiz_120   TGTTGTCCGCTAGGACGATGCGATTTCGGTTATTATTCAGAATGTCTTCGTTCTCTTTC    *Y. pestis*   pPCP1         6626--6684
  Y.pestis_Owiz_121   TGTCCGGGAGTGCTAATGCAGCATCATCTCAGTTAATACCAAATATATCCCCTGACAGC    *Y. pestis*   pPCP1         7878--7936
  Y.pestis_Owiz_127   GTGGAGATTCTGTCTCTATTGGCGGAGATGCTGCCGGTATTTCCAATAAAAATTATACTG   *Y. pestis*   pPCP1         8688--8747
  Y.pestis_Owiz_129   GAATCGCGCCCGGATATGTTTTAACGCGATTTTCAGACTCAGACAAATTCAGCAGAAT     *Y. pestis*   pPCP1         9990--10047
  Y.pestis_Owiz_147   TCGCTGGCTAAAAAGTACCATCCACATGCTCAACCCTATAACCTGTAGCTTACCCCAC     *Y. pestis*   pPCP1         9583--9640
  YpestisUPS_785      AATAGGTTATAACCAGCGCTTTTCTATGCCATATATTGGACTTGCAGGCCAGTATCGCAT   *Y. pestis*   pPCP1         8392--8451
  YpestisUPS_786      AATGATGAGCACTATATGAGAGATCTTACTTTCCGTGAGAAGACATCCGGCTCACGTTAT   *Y. pestis*   pPCP1         8510--8569
  YpestisUPS_787      TAAATTCAGCGACTGGGTTCGGGCACATGATAATGATGAGCACTATATGAGAGATCTTAC   *Y. pestis*   pPCP1         8479--8538
  Y.pestisUPS_788     AGCCCGACCACTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG   *Y. pestis*   pPCP1         4977--5036
  YpestisUPS_789      TCATCCTCCCCTAGCGGGGAGGATGTCTGTGGAAAGGAGGTTGGTGTTTGACCAACCTTC   *Y. pestis*   pPCP          8801--8860
  YpestisUPS_790      AAAGGACAGCATTTGGTATCTGTGCTCCACTTAAGCCAGCTACCACAGGTTAGAAAGCCT   *Y. pestis*   pPCP          5129--5188
  YpestisUPS_791      AAGGAGTGCGGGTAATAGGTTATAACCAGCGCTTTTCTATGCCATATATTGGACTTGCAG   *Y. pestis*   pPCP          8379--8438
  YpestisUPS_792      TTTGTACCGAGAACCTTTCACGGTATCGGCATATGGCCTGGGTAACTCAGGTCCGTAAAC   *Y. pestis*   pPCP          9451--9510

**Notes.**

The nucleotide position of each probe is based on the CP000310.1 *Yersinia pestis* Antiqua plasmid pPCP.

10.7717/peerj.2216/table-3

###### *Y. pestis* specific primers for standard end-point PCR and real-time PCR.

![](peerj-04-2216-g004)

  Forward Primer      Sequence (5^′^--3^′^)   Reverse primer      Sequence (5^′^--3^′^)          Probe           Sequence (5^′^--3^′^)                       Gene     Position
  ------------------- ----------------------- ------------------- ------------------------------ --------------- ------------------------------------------- -------- ---------------------------------------------
  Y.pes/pPCP/8374/F   CCCGAAAGGAG TGCGGGTAA   Y.pes/pPCP/8902/R   CGCCCCGTCATT ATGGTGAA          N/A             N/A                                         *pla*    8374--8902[^a^](#table-3fn1){ref-type="fn"}
  cafpri_f            CCAGCCCGCAT CACT        cafpri_r            ATCTGTAAAGTTAA CAGATGTGCTAGT   Tqpro_caf       JOE-AGCGTACCAA CAAGTAATTCTGTA TCGATG-BHQ1   *caf1*   109--255[^b^](#table-2fn2){ref-type="fn"}
  Y.pes_pPCP_F        AGACATCCGG CTCACGTTAT   Y.pes_pPCP_R        GAGTACCTCCT TTGCCCTCA          Y.pes_pPCP_Pr   FAM-CACCTAA TGCCAAAGTCTTT GCGGA-TAMRA       *pla*    8550--8669[^a^](#table-3fn1){ref-type="fn"}

**Notes.**

The nucleotide position of the Y.pes_pPCP_F and Y.pes_pPCP_R primers based on the CP000310.1 *Yersinia pestis* Antiqua plasmid pPCP.

The nucleotide position of the cafpri_f and cafpri_r primers based on the KF682424.1 *Yersinia pestis* strain S1 plasmid pMT1 capsule protein F1 (*caf1*) gene.

![Sequence showing how extracted DNA is used for sequence enrichment capture (A) and microarray hybridisation (B).](peerj-04-2216-g001){#fig-1}

Key findings
============

1.  Sequences homologous to the *pla* gene, which is present in *Y. pestis,* have been found in samples from several rodent species, in the absence of *Y. pestis*.

2.  PCR, microarray and sequencing data suggest that these sequences may be present in environmental bacteria.

3.  Caution is warranted in interpreting screening results for detection of *Y. pestis* when the *pla* gene is used as the sole marker for the presence of the pathogen.
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